BEAT
What one share of Heartbeam holds
Surgical and Medical Instruments and Apparatus
HeartBeam is a medical technology company focused on transforming cardiac care through the power of personalized insights. Our aim is to deliver innovative, higher resolution ambulatory cardiac monitoring solutions that can be used by patients anywhere to enable the detection and monitoring of cardiac disease outside of a healthcare facility.
Heartbeam’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.50 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$0.34 |
| Cash and investments | $0.15 |
| Book value | $0.15 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$0.29 | — | −$0.16 | — | −$1.36 |
| 2021 | — | −$1.03 | — | −$0.75 | — | $1.72 |
| 2022 | — | −$1.59 | $0.00 | −$1.22 | — | $0.30 |
| 2023 | — | −$0.72 | $0.01 | −$0.61 | — | $0.61 |
| 2024 | — | −$0.73 | $0.01 | −$0.55 | — | $0.06 |
| 2025 | — | −$0.62 | $0.02 | −$0.43 | — | $0.06 |